Small molecule inhibitors for the treatment or prevention of dengue virus infection
US9029376B2 · kind B2 · utility
20Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2009 |
| Grant date | May 12, 2015 |
| Priority date | — |
| Expiry date | Jul 27, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.